BioLargo Q2 2025 Earnings Results Webcast and Conference Call on Friday, August 15, 2025 - 11 AM Eastern Time
-
Iran hits targets across Middle East after Trump signals talks progress
-
McEvoy says best is to come after breaking long-standing swim record
-
Goat vs gecko: A tiny Caribbean island faces wildlife showdown
-
Japan PM asks IEA chief to prepare additional 'coordinated release' of oil
-
Hungary's hard-pressed LGBTQ people say Orban exit is only half battle
-
Belarus leader visits North Korea for first time
-
'No heavier burden': the decades-long search for Kosovo war missing
-
Exotic pet trade thrives in China despite welfare concerns
-
Iran fires missile salvo after Trump signals progress in talks
-
BTS concert drew 18.4 million viewers, says Netflix
-
OSCE's 'chaotic' Ukraine evacuation put staff at risk: leaked report
-
Top WTO official sounds fertiliser warning over Middle East war
-
France and Brazil weigh up World Cup prospects in glamour friendly
-
Italy hoping to end World Cup pain as play-offs loom
-
Dirty diapers born again in Japan recycling breakthrough
-
Verstappen's Japan GP win streak under threat as Mercedes dominate
-
Crude tumbles, stocks rally on hopes for Iran war de-escalation
-
Gauff outlasts Bencic to reach Miami semi-finals
-
'Hero' Australian dog who saved 100 koalas retires
-
Underdogs chase World Cup berths in Mexico playoff tournament
-
Pope heads to tiny Catholic Monaco
-
Meet the four astronauts set to voyage around the Moon
-
Artemis 2 Moon mission: a primer
-
It's go time: historic Moon mission set for lift-off
-
Denmark's PM Mette Frederiksen, tenacious and tough on migration
-
OpenAI kills Sora video app in pivot toward business tools
-
Danish PM's left-wing bloc wins election, but no majority
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - March 25
-
Apex Critical Metals Appoints Zayn Kalyan to Board of Directors
-
Troy Mick Appointed Head of SSS Phoenix Academy at Fire 'n' Ice Arena
-
Brazil court grants house arrest for jailed Bolsonaro
-
Sinner downs Michelsen to reach Miami Open quarter-finals
-
Advantage Arsenal in women's Champions League quarter-final against Chelsea
-
Garner dreams of World Cup glory in bid to replicate England under-21 success
-
New Mexico jury finds Meta liable for endangering children
-
Huge crowd in Buenos Aires marks 50 years since Argentina's coup
-
Oil, stock trading spiked before Trump's Iran remarks
-
Colombia military plane crash death toll rises to 69
-
Trump adds Columbus statue, walkway in latest White House makeover
-
Toronto unveils upgraded World Cup venue after fan scorn
-
Beerensteyn goal gives Wolfsburg edge over Lyon in women's Champions League
-
Gang crackdown carried out without 'abuses,' Guatemalan defense chief says
-
Afghanistan releases detained US citizen
-
Danish PM's left bloc leads election, but no majority
-
'Illustrious' Salah to leave Liverpool at the end of the season
-
Trump says Iran gave US 'gift' linked to Strait of Hormuz
-
US officials downplay controller 'distraction' in New York crash
-
Salah to leave Liverpool at the end of the season
-
Trump has destroyed Venezuela's socialist ideology: opposition leader
-
France urges Israel 'to refrain' from seizing south Lebanon zone
BioLargo Q2 2025 Earnings Results Webcast and Conference Call on Friday, August 15, 2025 - 11 AM Eastern Time
WESTMINSTER, CA / ACCESS Newswire / August 13, 2025 / BioLargo, Inc. (OTCQX:BLGO), a developer of sustainable technologies and full-service environmental engineering company, announced it will host an investor webcast and conference call on Friday, August 15th, 2025, at 8 am Pacific / 11 am Eastern. The event, which will be open to the public, will be held to review the company's financial results for the three months ending June 30th, 2025, discuss recent milestones, and conduct a question-and-answer session.
To listen to a live broadcast, go to the site linked below at least 15 minutes prior to the scheduled start time to register and download any necessary audio/video software.
To participate in the live webcast and teleconference:
Webcast Link: | |
Teleconference Domestic: | 877-506-0062 |
Teleconference International: Participant Access Code: | +1-973-528-0011 701430 |
To watch or listen to a replay of the webcast or teleconference:
Teleconference Replay Expiration: | Friday, August 29th, 2026 |
Teleconference Replay Domestic: | 877-481-4010 |
Teleconference Replay International: | 919-882-2331 |
Replay Passcode: | 52875 |
The webcast replay and accompanying presentation materials will be made available on the Investor Relations section of BioLargo's website at www.biolargo.com/investor-relations.
About BioLargo, Inc.
BioLargo, Inc. (OTCQX:BLGO) is a cleantech and life sciences innovator and engineering services solution provider. Our core products address PFAS contamination, achieve advanced water and wastewater treatment, control odor and VOCs, improve air quality, enable energy-efficiency and safe on-site energy storage, and control infections and infectious disease. Our approach is to invent or acquire novel technologies, develop them into product offerings, and extend their commercial reach through licensing and channel partnerships to maximize their impact. See our website at www.BioLargo.com.
Contact Information
Dennis P. Calvert
President and CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include without limitation those about BioLargo's (the "Company") expectations regarding anticipated revenue; and plans for future operations. These statements involve risks and uncertainties, and actual results may differ materially from any future results expressed or implied by the forward-looking statements. Risks and uncertainties include without limitation: the effect of regional economic conditions on the Company's business, including effects on purchasing decisions by consumers and businesses; the ability of the Company to compete in markets that are highly competitive and subject to rapid technological change; the ability of the Company to manage frequent introductions and transitions of products and services, including delivering to the marketplace, and stimulating customer demand for, new products, services, and technological innovations on a timely basis; the dependency of the Company on the performance of distributors of the Company's products. More information on these risks and other potential factors that could affect the Company's business and financial results is included in the Company's filings with the SEC, including in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of the Company's most recently filed periodic reports on Form 10-K and Form 10-Q and subsequent filings. The Company assumes no obligation to update any forward-looking statements or information, which speak as of their respective dates.
SOURCE: BioLargo, Inc
View the original press release on ACCESS Newswire
D.Johnson--AT
